These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26173169)

  • 1. The feasibility and safety of Algisyl-LVR™ as a method of left ventricular augmentation in patients with dilated cardiomyopathy: initial first in man clinical results.
    Lee RJ; Hinson A; Bauernschmitt R; Matschke K; Fang Q; Mann DL; Dowling R; Schiller N; Sabbah HN
    Int J Cardiol; 2015 Nov; 199():18-24. PubMed ID: 26173169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure.
    Mann DL; Lee RJ; Coats AJ; Neagoe G; Dragomir D; Pusineri E; Piredda M; Bettari L; Kirwan BA; Dowling R; Volterrani M; Solomon SD; Sabbah HN; Hinson A; Anker SD
    Eur J Heart Fail; 2016 Mar; 18(3):314-25. PubMed ID: 26555602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algisyl-LVR™ with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart.
    Lee LC; Wall ST; Klepach D; Ge L; Zhang Z; Lee RJ; Hinson A; Gorman JH; Gorman RC; Guccione JM
    Int J Cardiol; 2013 Oct; 168(3):2022-8. PubMed ID: 23394895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-based restoration of left ventricular mechanics.
    Lee RJ; Hinson A; Helgerson S; Bauernschmitt R; Sabbah HN
    Cell Transplant; 2013; 22(3):529-33. PubMed ID: 22469060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study.
    Frey N; Linke A; Süselbeck T; Müller-Ehmsen J; Vermeersch P; Schoors D; Rosenberg M; Bea F; Tuvia S; Leor J
    Circ Cardiovasc Interv; 2014 Dec; 7(6):806-12. PubMed ID: 25351198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes following surgical ventricular restoration for patients with clinically advanced congestive heart failure (New York Heart Association Class IV).
    Williams JA; Weiss ES; Patel ND; Nwakanma LU; Conte JV
    J Card Fail; 2007 Aug; 13(6):431-6. PubMed ID: 17675056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamically supported percutaneous coronary revascularization improves left ventricular function in patients with ischemic dilated cardiomyopathy at very high risk for surgery: a single-center experience.
    Gimelli G; Wolff MR
    J Invasive Cardiol; 2008 Dec; 20(12):642-6. PubMed ID: 19057027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure.
    Sabbah HN; Wang M; Gupta RC; Rastogi S; Ilsar I; Sabbah MS; Kohli S; Helgerson S; Lee RJ
    JACC Heart Fail; 2013 Jun; 1(3):252-8. PubMed ID: 23998003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilated cardiomyopathy with re-worsening left ventricular ejection fraction.
    Nabeta T; Inomata T; Ishii S; Yazaki M; Fujita T; Iida Y; Ikeda Y; Maekawa E; Naruke T; Koitabashi T; Ako J
    Heart Vessels; 2019 Jan; 34(1):95-103. PubMed ID: 29942977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior restoration procedures and the long-term results in indicated patients with dilated cardiomyopathy †.
    Isomura T; Hirota M; Notomi Y; Hoshino J; Kondo T; Takahashi Y; Yoshida M
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):725-31; discussion 731. PubMed ID: 25736271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year clinical experience with the Acorn CorCap cardiac support device: results of a limited market release safety study in Italy and Sweden.
    Livi U; Alfieri O; Vitali E; Russo C; Frigerio M; Tursi V; Albanese MC; De Bonis M; Fragasso G; Franco-Cereceda A; Forssell G; Rorke R; Kubo SH
    Ital Heart J; 2005 Jan; 6(1):59-65. PubMed ID: 15773275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial).
    Anker SD; Coats AJ; Cristian G; Dragomir D; Pusineri E; Piredda M; Bettari L; Dowling R; Volterrani M; Kirwan BA; Filippatos G; Mas JL; Danchin N; Solomon SD; Lee RJ; Ahmann F; Hinson A; Sabbah HN; Mann DL
    Eur Heart J; 2015 Sep; 36(34):2297-309. PubMed ID: 26082085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of apex-sparing partial left ventriculectomy on left ventricular geometry, function, and long-term survival of patients with end-stage dilated cardiomyopathy.
    Nishina T; Shimamoto T; Marui A; Komeda M
    J Card Surg; 2009; 24(5):499-502. PubMed ID: 19740283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right and left ventricular dysfunction in patients with dilated cardiomyopathy: a study with equilibrium radionuclide ventriculography.
    Araki H; Caglar N; Hisano R; Nagata Y; Ogata I; Fukuyama T; Nakamura M
    J Cardiogr; 1985 Mar; 15(1):155-61. PubMed ID: 4067341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter left atrial decompression in patients with dilated cardiomyopathy: bridging to cardiac transplantation or recovery.
    Bauer A; Khalil M; Schmidt D; Recla S; Bauer J; Esmaeili A; Penford G; Akintuerk H; Schranz D
    Cardiol Young; 2019 Mar; 29(3):355-362. PubMed ID: 30806346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy.
    O'Neill JO; Starling RC; McCarthy PM; Albert NM; Lytle BW; Navia J; Young JB; Smedira N
    Eur J Cardiothorac Surg; 2006 Nov; 30(5):753-9. PubMed ID: 17023172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and prognostic significance of echocardiographic parameters in dilated cardiomyopathy: a prospective study on 225 patients. The Italian Multicenter Study of Cardiomyopathies Group].
    Sachero A; Casazza F; Recalcati F; de Maria R; Preti L; Mattioli R; Ferrari F; Capozzi A; Camerini F
    G Ital Cardiol; 1992 Sep; 22(9):1077-90. PubMed ID: 1291425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy.
    Dandel M; Weng Y; Siniawski H; Potapov E; Drews T; Lehmkuhl HB; Knosalla C; Hetzer R
    Circulation; 2008 Sep; 118(14 Suppl):S94-105. PubMed ID: 18824777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour holter electrocardiography.
    Grimm W; Glaveris C; Hoffmann J; Menz V; Müller HH; Hufnagel G; Maisch B
    Am Heart J; 2000 Jul; 140(1):43-51. PubMed ID: 10874262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.